Cite
Mirtazapine, an α2 Antagonist-Type Antidepressant, Reverses Pain and Lack of Morphine Analgesia in Fibromyalgia-Like Mouse Models
MLA
Hiroshi Ueda, et al. “Mirtazapine, an Α2 Antagonist-Type Antidepressant, Reverses Pain and Lack of Morphine Analgesia in Fibromyalgia-Like Mouse Models.” Journal of Pharmacology and Experimental Therapeutics, vol. 375, July 2020, pp. 1–9. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........8b9dd538b5c57fcd807ee44552732222&authtype=sso&custid=ns315887.
APA
Hiroshi Ueda, Naoki Dozono, Hitoshi Uchida, & Hiroyuki Neyama. (2020). Mirtazapine, an α2 Antagonist-Type Antidepressant, Reverses Pain and Lack of Morphine Analgesia in Fibromyalgia-Like Mouse Models. Journal of Pharmacology and Experimental Therapeutics, 375, 1–9.
Chicago
Hiroshi Ueda, Naoki Dozono, Hitoshi Uchida, and Hiroyuki Neyama. 2020. “Mirtazapine, an Α2 Antagonist-Type Antidepressant, Reverses Pain and Lack of Morphine Analgesia in Fibromyalgia-Like Mouse Models.” Journal of Pharmacology and Experimental Therapeutics 375 (July): 1–9. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........8b9dd538b5c57fcd807ee44552732222&authtype=sso&custid=ns315887.